AMH provides a guide to the functional potential of the Ovary, however, it cannot predict oocyte quality or predict the future rate of decline. It is often used as a guide to identify women that may need to consider either egg retrieval and freezing or assist a woman in deciding to try for a pregnancy sooner rather than later if their long-term future fertility is likely to be poor. AMH can indicate the potential ovarian response to stimulation in the IVF process, however, it cannot predict success of treatment. Interpretation of a result is age specific.
Anti Mullerian Hormone (AMH)
Anti Mullerian Hormone (AMH)
Anti Mullerian Hormone (AMH), is a hormone produced by the ovarian granulosa cells in women and is most commonly used in initial fertility investigations to assess ovarian reserve.
Whilst AMH is most commonly associated with fertility, it is also used in women with suspected premature ovarian insufficiency before a diagnosis is confirmed.
Measuring AMH alone may be misleading as high levels occur in conditions like polycystic ovarian syndrome. Here the presence of a large number of small follicles can elevate the serum AMH 2-5 fold higher than the age-specific ranges. Therefore AMH levels should be considered in conjunction with a transvaginal scan of the ovaries to assess ovarian volume and to estimate antral follicle count.
AMH is sometimes used as a tumour marker in the surveillance of granulosa cell ovarian tumours.
5mL venous serum
In addition to the packaging of samples, the transport/delivery of clinical samples to the laboratory is required to be in adherence to all national regulations for the safe transport of biological materials. Enfer Medical provides a fully compliant logistics service, aligned with clients’ testing requirements.
Prompt transport of specimens:
To ensure prompt testing of samples and release of results within the published test turnaround times, samples should arrive to the laboratory by 18:00. Test turnaround time is measured from receipt of the sample at the laboratory until the time the authorised results are reported to users.
In rare cases specimens may not be suitable for testing on arrival to the laboratory. In that case the sample will be rejected at the receipt stage and the service user will be notified immediately and an explanation as to why the sample could not be processed will be provided. Reasons why samples cannot be processed include but are not limited to:
- Samples received beyond the stability limits and/or not at the correct temperature indicated for each test.
- Incorrect sample type received.
- Leaking samples, sample not received or sample insufficient for analysis as stated below within sample requirements.
- Non-compliant samples or request forms i.e. those missing sample date information, missing sample test request and/or missing sample site/type information.
- Samples received without the necessary patient identifiers.
Quantitative results for AMH are reported in numeric value in pmol/L. Please contact us for more information on the reference ranges used at Enfer Medical.